• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

The Asthma and Allergy Foundation of America (AAFA) Available to Comment on Asthma Study in the New England Journal of Medicine (NEJM)

Posted on: Wednesday, 13 April 2005, 18:00 CDT

WASHINGTON, April 13 /PRNewswire/ --

WHAT: New asthma findings suggest that some adults with mild persistent

asthma may be able to adequately control their asthma by taking

corticosteroids only when needed instead of taking

anti-inflammatory medication daily

WHO: The Asthma and Allergy Foundation of America (AAFA), a

not-for-profit organization, and is the leading patient

organization for people with asthma and allergies

-- Spokesperson can discuss the following:

* Current guidelines recommend inhaled corticosteroids as safe,

effective and preferred first-line therapy for children as well

as adults with persistent asthma

* There is potential for confusion among patients and physicians

as a result of the IMPACT study

* Patients should not discontinue any prescribed medications

until advised by their physician

* The Impact study published in NEJM is preliminary

* Additional research needs to be conducted to confirm findings

from the Impact study

-- AAFA also can refer reporters to a physician for a clinical

perspective on the IMPACT study

The Asthma and Allergy Foundation of America

CONTACT: Mike Tringale, Communications Director, AAFA, +1-202-466-7643,ext. 272, mike@aafa.org

Source: PRNewswire

More News in this Category